Boosting Smell Training in Adults with HIV
Official title: A Feasibility and Acceptability Study Testing Two Types of Smell Exposure Interventions in Middle-Aged Older Adults With HIV
Run by University of Alabama at Birmingham · NCT07221123 · Data updated 2026-11-12
This study tests two at-home smell-training methods to see if they improve scent function and thinking skills in adults with HIV.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Birmingham, Alabama) |
| Status | Recruiting |
| Started | May 2, 2026 |
| Main results expected | July 1, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | June 11, 2026 |
| Trial ID | NCT07221123 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40 or older with HIV and self-reported cognitive complaints, who are proficient in English and able to attend in-person visits within 60 miles of the center.
✕Probably not a fit
Participants with recent nasal infections, significant neuro-comorbidities, or other exclusion criteria may not benefit from the training.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 2 trial compares conventional at-home olfactory training with a scented marker training approach over 8 weeks in adults living with HIV. Participants are randomized to one of the two interventions after a baseline assessment, then return for a post-intervention evaluation of olfactory and cognitive performance. The study uses a two-group pre-post design and stratified randomization by gender and smoking status to control for potential confounders. Recruitment is from the UAB 1917 HIV/AIDS Clinic, with in-person baseline and posttest visits and customary follow-up procedures. The primary goals are to assess feasibility and acceptability as well as any improvements in olfactory and cognitive function.
Why it matters
Potential benefit: If successful, participants could experience improved sense of smell and related cognitive benefits from the training.
How similar studies have gone: Prior olfactory training studies suggest potential sensory benefits, but this specific HIV-focused, home-based, two-arm approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants (men \& women) must be 40+ years * have cognitive complaints. * must be proficient in English Exclusion Criteria: * a sinus infection (within the past 3 months), thrush, candidiasis, pregnant, current cold or flu, hay fever, asthma, nasal allergies, opportunistic infections (including COVID-19) within the past 3 months, or current nasal obstruction condition. * Participation requires \~8 weeks and in-person visits, participants living beyond 60 miles away from the center will be excluded. * Participants living in unstable housing (e.g., shelter) or with significant neuro-comorbidities (e.g., schizophrenia) will be excluded. * Other conditions (e.g., legally blind/deaf, currently undergoing radiation or chemotherapy, or a history of significant brain trauma) that could impact olfactory and cognitive testing also necessitate exclusion.
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting
Study contacts
- Study coordinator: David E Vance, PhD
- Email: devance@uab.edu
- Phone: 1205-934-7589
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Multiple interventions to try for HIV remission in people on ART
This study tests a combination approach, including intensified ART, latency-reversal agents, and autologous dendritic cell therapy, to see if people living with HIV on long-term ART can achieve sustained viral suppression or prolonged remission.
-
Portable chest X-ray screening to rapidly find TB in migrants
A community-based TB screening effort using mobile chest X-rays and AI-assisted readings is tested among migrant adults in New York City to see if it helps identify active TB earlier and connect people to care.
-
Two-probe thermal ablation for cervical precancer in WLWH in South Africa
This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in South Africa.
-
Two-probe thermal ablation for cervical precancer in WLWH in Zimbabwe
This study tests whether using two TA probes (endocervical and ectocervical) is better than one probe for treating cervical precancer in women living with HIV in Zimbabwe.
-
TransAction program to improve HIV prevention and care for transgender women in Ho Chi Minh City
This trial will test whether TransAction—individual risk-reduction sessions, skill-building and group support, plus social events—helps transgender women in Ho Chi Minh City move forward in HIV prevention and care compared with social events alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.